Related Articles
New Sleep Medication Approved: Daridorexant (Quviviq)
On Jan 10, 2022, FDA has approved this new medication for treatment of adults with insomnia: Quviviq (daridorexant). This FDA approval is based on the…
Our Top 5 Posts & Lecture Series of 2019: Happy New Year
We hope you had an amazing 2019! We sure did, thanks to all of your support over the past year. I want to say a…
Dasotraline: New Norepinephrine-Dopamine Reuptake Inhibitor
Dasotraline is an investigational medication discovered by Sunovion Pharmaceuticals Inc. and is currently under development for the treatment of: ADHD (in children) and Binge eating…
Lumateperone (Caplyta): New Antipsychotic Approved for Schizophrenia
FDA has approved this new antipsychotic CAPLYTA (lumateperone) for the treatment of schizophrenia. This post will summarize the important clinically relevant facts regarding this medication,…
Journal Club #1: Update on Nonpsychotic Unipolar Depression Management
We begin PEFA Journal Club’s updated schedule with our first journal club discussion today: Journal Club #1: The Psychopharmacology Algorithm Project at the Harvard South…